Get started
Roche Holding LtdRoche Holding LtdRoche Holding Ltd

Roche Holding Ltd

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFsBonds
Full chart
Full chart

Compare with Roche Holding Ltd



Key stats


Market capitalization
‪284.80 B‬ CHF
Dividend yield (indicated)
2.75%
Price to earnings Ratio (TTM)
23.3
Basic EPS (TTM)
15.5 CHF
Net income (FY)
‪12.88 B‬ CHF
Revenue (FY)
‪61.52 B‬ CHF
Shares float
‪688.93 M‬
Beta (1Y)
1.40

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪112.77 K‬
Change (1Y)
‪+9.53 K‬+9.23%
Revenue / Employee (1Y)
‪545.48 K‬ CHF
Net income / Employee (1Y)
‪114.21 K‬ CHF

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Schinecker
Website
roche.com
Headquarters
Basel
Founded
1896
ISIN
CH1499059983
FIGI
BBG020ZHBNF2
Identifiers
ISIN CH1499059983
CFI code
ESNUFB
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight0.68%
Market value‪4.53 B‬
VEA
Vanguard FTSE Developed Markets ETF
Weight0.94%
Market value‪3.02 B‬
IEFA
iShares Core MSCI EAFE ETF
Weight1.18%
Market value‪2.32 B‬
CHDVD
iShares Swiss Dividend ETF (CH)
Weight15.07%
Market value‪1.56 B‬
EFA
iShares MSCI EAFE ETF
Weight1.39%
Market value‪1.10 B‬
CHSPI
iShares Core SPI(R) ETF (CH)
Weight13.05%
Market value‪951.18 M‬
VGK
Vanguard FTSEEuropean ETF
Weight1.89%
Market value‪735.21 M‬
VEU
Vanguard FTSE All World Ex US ETF
Weight0.75%
Market value‪732.76 M‬
SCHF
Schwab International Equity ETF
Weight1.02%
Market value‪708.90 M‬
CHEURD.EUR
UBS ETF SICAV - UBS ETF - MSCI Switzerland 20/35 UCITS ETF -(hedged to EUR) A-dis- Distribution
Weight14.60%
Market value‪657.75 M‬
SW2CHB
UBS ETF SICAV - UBS ETF - MSCI Switzerland 20/35 UCITS ETF A Capitalisation
Weight14.60%
Market value‪657.75 M‬

Explore more ETFs 

Frequently asked questions


The current price of ROP is 357.0 CHF — it has increased by 0.14% in the past 24 hours. Watch Roche Holding Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Roche Holding Ltd stocks are traded under the ticker ROP.
ROP stock has fallen by −2.46% compared to the previous week, the month change is a −0.70% fall, over the last year Roche Holding Ltd has showed a 32.47% increase.
We've gathered analysts' opinions on Roche Holding Ltd future price: according to them, ROP price has a max estimate of 434.50 CHF and a min estimate of 230.00 CHF. Watch ROP chart and read a more detailed Roche Holding Ltd stock forecast: see what analysts think of Roche Holding Ltd and suggest that you do with its stocks.
ROP reached its all-time high on Apr 11, 2022 with the price of 404.2 CHF, and its all-time low was 73.4 CHF and was reached on Mar 12, 2003. View more price dynamics on ROP chart.
See other stocks reaching their highest and lowest prices.
ROP stock is 1.62% volatile and has beta coefficient of 1.40. Track Roche Holding Ltd stock price on the chart and check out the list of the most volatile stocks — is Roche Holding Ltd there?
Today Roche Holding Ltd has the market capitalization of ‪284.04 B‬, it has decreased by −5.51% over the last week.
Yes, you can track Roche Holding Ltd financials in yearly and quarterly reports right on TradingView.
Roche Holding Ltd is going to release the next earnings report on Feb 4, 2027. Keep track of upcoming events with our Earnings Calendar.
ROP earnings for the last half-year are 10.85 CHF per share, whereas the estimation was 10.11 CHF, resulting in a 7.33% surprise. The estimated earnings for the next half-year are 9.65 CHF per share. See more details about Roche Holding Ltd earnings.
Roche Holding Ltd revenue for the last half-year amounts to ‪31.45 B‬ CHF, despite the estimated figure of ‪30.43 B‬ CHF. In the next half-year revenue is expected to reach ‪32.32 B‬ CHF.
ROP net income for the last half-year is ‪6.87 B‬ CHF, while the previous report showed ‪5.47 B‬ CHF of net income which accounts for 0.00% change. Track more Roche Holding Ltd financial stats to get the full picture.
Yes, ROP dividends are paid annually. The last dividend per share was 9.80 CHF. As of today, Dividend Yield (TTM)% is 2.75%. Tracking Roche Holding Ltd dividends might help you take more informed decisions.
Roche Holding Ltd dividend yield was 2.99% in 2025, and payout ratio reached 60.57%. The year before the numbers were 3.80% and 93.40% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 7, 2026, the company has ‪112.77 K‬ employees. See our rating of the largest employees — is Roche Holding Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Roche Holding Ltd EBITDA is ‪22.07 B‬ CHF, and current EBITDA margin is 36.83%. See more stats in Roche Holding Ltd financial statements.
Like other stocks, ROP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Roche Holding Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Roche Holding Ltd technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Roche Holding Ltd stock shows the buy signal. See more of Roche Holding Ltd technicals for a more comprehensive analysis.